In patients with CCD who also have hypertension, diabetes, LVEF ≤ 40%, or CKD, the use of ACE inhibitors, or ARBs for those intolerant to ACE inhibitors, is recommended.7 This evidence concerns the gene ACE and chronic kidney disease.